Leverage Shares PLC Notice of Change in Name of ARK ETP Securities (8139F)

TIDM3ARG TIDMSARG TIDMARKC TIDM3ARW

RNS Number : 8139F

Leverage Shares PLC

23 March 2022

Leverage Shares plc

23 March 2022

THIS NOTICE IS IMPORTANT AND REQUIRES THE IMMEDIATE ATTENTION OF THE HOLDERS OF THE ETP SECURITIES. IF ANY ETP SECURITYHOLDER IS IN ANY DOUBT AS TO THE ACTION THEY SHOULD TAKE, THEY SHOULD CONSULT THEIR OWN INDEPENDENT PROFESSIONAL ADVISERS IMMEDIATELY

If you have recently sold or otherwise transferred your entire holding(s) of ETP Securities referred to below, you should immediately forward this document to the purchaser or transferee or to the stockbroker, bank or other agent through whom the sale or transfer was effected for transmission to the purchaser or transferee.

NOTICE OF CHANGE OF NAME OF THE FOLLOWING SERIES OF ETP SECURITIES

Leverage Shares 3x Long ARKG Genomic ETP Securities (ISIN: XS2399367767)

Leverage Shares -3x Short ARKG Genomic ETP Securities (ISIN: XS2399367841)

LS ARKG Genomic Tracker ETP (ISIN: XS2399368062)

Leverage Shares 3x Long ARKW NextGen Internet ETP Securities (ISIN: XS2399368146)

Leverage Shares -3x Short ARKW NextGen Internet ETP Securities (ISIN: XS2399368492)

LS ARKW NextGen Internet Tracker ETP (ISIN: XS2399368575)

Leverage Shares 3x Long ARKK Innovation ETP Securities (ISIN: XS2399368658)

Leverage Shares -3x Short ARKK Innovation ETP Securities (ISIN: XS2399368906)

LS ARKK Innovation Tracker ETP (ISIN: XS2399369037)

(the "Relevant Series")

Leverage Shares plc (the "Issuer") hereby gives notice that with effect from 30 March 2022, the name of each of the Relevant Series will be changed to the new corresponding name as referenced below. Please note that the ISIN of each of the Relevant Series will remain unchanged.

 
 Existing Name of Relevant Series          New Name of Relevant Series 
 Leverage Shares 3x Long ARKG Genomic      Leverage Shares 3x Long ARK 
  ETP Securities                            Genomic ETP Securities 
                                          --------------------------------- 
 Leverage Shares -3x Short ARKG            Leverage Shares -3x Short ARK 
  Genomic ETP Securities                    Genomic ETP Securities 
                                          --------------------------------- 
 LS ARKG Genomic Tracker ETP               LS ARK Genomic Tracker ETP 
                                          --------------------------------- 
 Leverage Shares 3x Long ARKW NextGen      Leverage Shares 3x Long ARK 
  Internet ETP Securities                   NextGen Internet ETP Securities 
                                          --------------------------------- 
 Leverage Shares -3x Short ARKW            Leverage Shares -3x Short ARK 
  NextGen Internet ETP Securities           NextGen Internet ETP Securities 
                                          --------------------------------- 
 LS ARKW NextGen Internet Tracker          LS ARK NextGen Internet Tracker 
  ETP                                       ETP 
                                          --------------------------------- 
 Leverage Shares 3x Long ARKK Innovation   Leverage Shares 3x Long ARK 
  ETP Securities                            Innovation ETP Securities 
                                          --------------------------------- 
 Leverage Shares -3x Short ARKK            Leverage Shares -3x Short ARK 
  Innovation ETP Securities                 Innovation ETP Securities 
                                          --------------------------------- 
 LS ARKK Innovation Tracker ETP            LS ARK Innovation Tracker ETP 
                                          --------------------------------- 
 

Capitalised terms used, but not defined, in this notice shall have the meaning given thereto in the Issuer's Base Prospectus dated 7 December 2021.

If you have any queries arising from this notice, please contact us at [e-mail] .

Yours sincerely

The Directors

Leverage Shares plc

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

MSCQXLFLLXLEBBE

(END) Dow Jones Newswires

March 23, 2022 13:00 ET (17:00 GMT)